Skip to main content

Use our new AI tool to learn how federal programs are designed to fight fraud.

X
Skip to list of content Filter By:

Date Range

Refine these results:

By Agency

By Topic

Search

Showing 2091 - 2100 of 4016 results

Federal American Rescue Plan Act Funding for COVID-19 March 2022

The primary objective of this report is to show Missouri's spending of federal assistance from the American Rescue Plan Act in the month of March 2022 for the COVID-19 recovery and the cumulative financial activity since the state began receiving funding in May 2021.

Federal American Rescue Plan Act Funding for COVID-19 Recovery February 2022

The primary objective of this report is to show Missouri's spending of federal assistance from the American Rescue Plan Act in the month of February 2022 for COVID-19 recovery and the cumulative financial activity since the state began receiving funding in May 2021.

Federal Funding for COVID-19 Response November 2021

The primary objective of this report is to show Missouri's spending of federal assistance in the month of November 2021 for the COVID-19 emergency and the cumulative financial activity since the state began receiving funding in April 2020.

Federal Funding for COVID-19 Response October 2021

The primary objective of this report is to show Missouri's spending of federal assistance in the month of October 2021 for the COVID-19 emergency and the cumulative financial activity since the state began receiving funding in April 2020.

The IRS’s Inability to Keep Pace with Non-Corporate Applications for Refund of Net Operating Losses Under the CARES Act Has Cost Taxpayers Millions of Dollars in Additional Interest

Audit of the Help America Vote Act Grants Awarded to the State of Washington

EAC OIG, through the independent public accounting firm of McBride, Lock & Associates, LLC, audited funds received by the State of Washington under the Help America Vote Act, including state matching funds and program income, totaling $30.3 million. This included Election Security and Coronavirus Aid, Relief, and Economic Security Act grants.

Medical Technology Company President Convicted in $77 Million COVID-19 and Allergy Testing Scheme

A federal jury convicted the president of a Silicon Valley-based medical technology company today of participating in a scheme to mislead investors, commit health care fraud, and pay illegal kickbacks in connection with the submission of over $77 million in false and fraudulent claims for COVID-19 and allergy testing.